Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
Illumina CEO Francis deSouza Resigns Amid Regulatory Hurdles, Proxy Fight
Read moreDetails
Tag: Genomics
Carl Icahn and Illumina Proxy Fight Consequence: CEO Survives, Chairman Is Out
Activist investor Carl Icahn needs a gain at Illumina just after a string of issues elsewhere. Photograph by Victor J. ...
Read moreDetails
Cologuard Maker Correct Sciences Reviews Significant Revenue and a Surprise Revenue
Most cancers-screening corporation Exact Sciences hadn’t anticipated to report income earnings until this year’s September quarter. But the seller of ...
Read moreDetails
ARK’s Cathie Wood Suggests Tesla Inventory Has ‘Miles to Run’
Several buyers have been functioning away from Tesla inventory in new weeks, apprehensive about disappointing auto revenue and no matter ...
Read moreDetailsARK’s Cathie Wooden Says Tesla Inventory Has ‘Miles to Run’
A lot of investors have been functioning absent from Tesla stock in modern weeks, fearful about disappointing car sales and ...
Read moreDetails
ARK’s Cathie Wood Is Obtaining More Beaten-Down Tesla Inventory
Tesla stock has been going through a tricky patch. ARK Invest’s founder Cathie Wood utilised the downdraft as an opportunity ...
Read moreDetails
Bio-Rad Laboratories in Talks to Incorporate With Qiagen
Bio-Rad Laboratories is in talks to merge with fellow life-sciences organization Qiagen NV in a offer that would be well ...
Read moreDetails